Human swayback disease: expanding the spectrum of diseases associated with abnormal copper metabolismGIOVANNONI, Gavin.Journal of neurology. 2001, Vol 248, Num 8, issn 0340-5354, p. 707Article

Management of secondary-progressive multiple sclerosisGIOVANNONI, Gavin.CNS drugs. 2004, Vol 18, Num 10, pp 653-669, issn 1172-7047, 17 p.Article

Strategies to treat and prevent the development of neutralizing anti-interferon-β antibodiesGIOVANNONI, Gavin.Neurology. 2003, Vol 61, Num 9, pp S13-S17, issn 0028-3878, SUP5Conference Paper

Neutralizing anti-IFN-β antibodies : How much more evidence do we need to use them in practice?GIOVANNONI, Gavin; GOODMAN, Andrew.Neurology. 2005, Vol 65, Num 1, pp 6-8, issn 0028-3878, 3 p.Article

Measuring and management of Anti-Interferon Beta Antibodies in subjects with Multiple SclerosisFARRELL, Rachel A; GIOVANNONI, Gavin.Multiple sclerosis. 2007, Vol 13, Num 5, pp 567-577, issn 1352-4585, 11 p.Article

The McDonald Criteria for Multiple Sclerosis: time for clarificationHAWKES, Christopher H; GIOVANNONI, Gavin.Multiple sclerosis. 2010, Vol 16, Num 5, pp 566-575, issn 1352-4585, 10 p.Article

Are antibasal ganglia antibodies important, and clinically useful?MARTINO, Davide; CHURCH, Andrew; GIOVANNONI, Gavin et al.Practical neurology (Print). 2007, Vol 7, Num 1, pp 32-41, issn 1474-7758, 10 p.Article

Optimising MS disease-modifying therapies: antibodies in perspectiveGIOVANNONI, Gavin.Journal of neurology. Supplement. 2004, Vol 251, Num 5, pp V.30-V.35, issn 0939-1517Article

Comparison of Two Commercial ELISA Systems for Evaluating Anti-EBNA1 IgG TitersDOBSON, Ruth; TOPPING, Joanne; GIOVANNONI, Gavin et al.Journal of medical virology. 2013, Vol 85, Num 1, pp 128-131, issn 0146-6615, 4 p.Article

Bone health and multiple sclerosisDOBSON, Ruth; RAMAGOPALAN, Sreeram; GIOVANNONI, Gavin et al.Multiple sclerosis. 2012, Vol 18, Num 11, pp 1522-1528, issn 1352-4585, 7 p.Article

The effect of gender in clinically isolated syndrome (CIS): a meta-analysisDOBSON, Ruth; RAMAGOPALAN, Sreeram; GIOVANNONI, Gavin et al.Multiple sclerosis. 2012, Vol 18, Num 5, pp 600-604, issn 1352-4585, 5 p.Article

Mifepristone or inhibition of 11β-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Δ(9)-tetrahydrocannabinol in micePRYCE, Gareth; GIOVANNONI, Gavin; BAKER, David et al.Neuroscience letters. 2003, Vol 341, Num 2, pp 164-166, issn 0304-3940, 3 p.Article

The PANDAS subgroup of tic disorders and childhood-onset obsessive―compulsive disorder : The many faces of Gilles de la Tourette syndromeMARTINO, Davide; DEFAZIO, Giovanni; GIOVANNONI, Gavin et al.Journal of psychosomatic research. 2009, Vol 67, Num 6, pp 547-557, issn 0022-3999, 11 p.Article

Surviving stiff-person syndrome: a case reportGNANAPAVAN, Sharmilee; VINCENT, Angela; GIOVANNONI, Gavin et al.Journal of neurology. 2011, Vol 258, Num 10, pp 1898-1900, issn 0340-5354, 3 p.Article

Multiple sclerosis: a practical overview for cliniciansREJDAK, Konrad; JACKSON, Samuel; GIOVANNONI, Gavin et al.British medical bulletin. 2010, Vol 95, pp 79-104, issn 0007-1420, 26 p.Article

Stiff person syndromeHADAVI, Shahrzad; NOYCE, Alastair J; DAVID LESLIE, R et al.Practical neurology (Print). 2011, Vol 11, Num 5, pp 272-282, issn 1474-7758, 11 p.Article

The implications of immunogenicity for protein-based multiple sclerosis therapiesCOHEN, Bruce A; OGER, Joel; GAGNON, Alison et al.Journal of the neurological sciences. 2008, Vol 275, Num 1-2, pp 7-17, issn 0022-510X, 11 p.Article

The clinical significance of an intrathecal monoclonal immunoglobulin band: A follow-up studyDAVIES, Gerard; KEIR, Geoff; THOMPSON, Edward J et al.Neurology. 2003, Vol 60, Num 7, pp 1163-1166, issn 0028-3878, 4 p.Article

Incidence of anti-brain antibodies in children with obsessive-compulsive disorderDALE, Russell C; HEYMAN, Isobel; GIOVANNONI, Gavin et al.British journal of psychiatry (Print). 2005, Vol 187, Num OCT, pp 314-319, issn 0007-1250, 6 p.Article

Primary CNS mantle cell lymphoma associated with an isolated CSF monoclonal IgG bandTRIP, S. Anand; WROEA, Stephen J; DAVIES, Gerard et al.European neurology. 2003, Vol 49, Num 3, pp 187-188, issn 0014-3022, 2 p.Article

Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitisAL-IZKI, Sarah; PRYCE, Gareth; JACKSON, Samuel J et al.Multiple sclerosis. 2011, Vol 17, Num 8, pp 939-948, issn 1352-4585, 10 p.Article

Spread of T lymphocyte immune responses to myelin epitopes with duration of multiple sclerosisDAVIES, Selina; NICHOLSON, Tim; LAURA, Matilde et al.Journal of neuropathology and experimental neurology. 2005, Vol 64, Num 5, pp 371-377, issn 0022-3069, 7 p.Article

Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta-1aDUBOIS, Bénédicte; LEARY, Siobhan M; NELISSEN, Inge et al.Journal of neurology. 2003, Vol 250, Num 9, pp 1037-1043, issn 0340-5354, 7 p.Article

The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysisJAMES, Eleanor; DOBSON, Ruth; KUHLE, Jens et al.Multiple sclerosis. 2013, Vol 19, Num 12, pp 1571-1579, issn 1352-4585, 9 p.Article

Sex ratio of infectious mononucleosis and possible relevance to multiple sclerosisRAMAGOPALAN, Sreeram V; GIOVANNONI, Gavin; YEATES, David G et al.Multiple sclerosis. 2013, Vol 19, Num 3, pp 359-361, issn 1352-4585, 3 p.Article